Research
Serum proteomics in newborns reveals a multi-pathway molecular panel for neonatal sepsis, encompassing pathogen sensing, leukocyte recruitment, and endothelial injury
Nature ·
The Brief
- A study published in Nature's subject feeds on 2026-11-14 reports a serum proteomics analysis in newborns.
- The reported panel spans pathogen sensing, leukocyte recruitment, and endothelial injury pathways.
- The source provided no summary, so specific protein names, sample sizes and diagnostic performance figures are not available here.
Why it matters
Neonatal sepsis is hard to diagnose early, so a blood-based molecular panel covering several biological pathways could, if validated, inform future diagnostic tests for newborns.
Who’s affected
- neonatologists and pediatric clinicians
- researchers in proteomics and infectious disease diagnostics
- #neonatal sepsis
- #proteomics
- #serum biomarkers
- #diagnostics
- #newborns